[HTML][HTML] Type I interferon-mediated autoinflammation due to DNase II deficiency

…, B Neven, P Nitschke, T Pascreau, S Pastore… - Nature …, 2017 - nature.com
Microbial nucleic acid recognition serves as the major stimulus to an antiviral response,
implying a requirement to limit the misrepresentation of self nucleic acids as non-self and the …

Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study

…, K Pagava, V Panaviene, S Pastore… - The Lancet Child & …, 2019 - thelancet.com
Background To our knowledge, the characteristics and burden of childhood arthritis have
never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional study…

Describing Kawasaki shock syndrome: results from a retrospective study and literature review

A Taddio, ED Rossi, L Monasta, S Pastore… - Clinical …, 2017 - Springer
Kawasaki shock syndrome (KSS) is a rare manifestation of Kawasaki disease (KD) characterized
by systolic hypotension or clinical signs of poor perfusion. The objectives of the study …

[HTML][HTML] ANCA-associated vasculitis in childhood: recent advances

…, RA Sinico, F Pieruzzi, G Moroni, S Pastore… - Italian journal of …, 2017 - Springer
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides are rare systemic
diseases that usually occur in adulthood. They comprise granulomatosis with polyangiitis (GPA, …

Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial

…, Y Uziel, I Tirosh, L Harel, R Caorsi, S Pastore… - The Lancet, 2023 - thelancet.com
Background Juvenile idiopathic arthritis can be refractory to some or all treatment regimens,
therefore new medications are needed to treat this population. This trial assessed the …

The resurgence of rheumatic fever in a developed country area: the role of echocardiography

S Pastore, A De Cunto, A Benettoni, E Berton… - …, 2011 - academic.oup.com
Objectives. The annual incidence of ARF ranges from 5 to 51/100 000 population worldwide
in the 5- to 15-year age group. In the past, there was a decline in the incidence of ARF; …

[HTML][HTML] A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry

…, S Martino, AN Olivieri, G Fabio, S Pastore… - Pediatric …, 2017 - Springer
Background Behçet’s disease is a rare multi-systemic inflammatory disease with unknown
etiology which involves principally oral and genital mucosa, skin and eyes. Average age at …

Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases

…, C Esposito, M Lepretti, S Pastore… - Clinical & …, 2010 - academic.oup.com
Anti-transglutaminase antibodies are the diagnostic markers of coeliac disease. A role is
suggested for infectious agents in the production of anti-transglutaminase antibodies. The aim …

Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis

…, C Bracaglia, DP Marafon, S Pastore… - The Journal of …, 2018 - jrheum.org
Objective. Anti-TNF-α agents have significantly changed the management of juvenile idiopathic
arthritis (JIA). We evaluated the safety and efficacy of adalimumab (ADA) and infliximab (…

[HTML][HTML] Dealing with chronic non-bacterial osteomyelitis: a practical approach

…, M Pardeo, M Gregori, M Finetti, S Pastore… - Pediatric …, 2017 - Springer
Background Chronic Non-Bacterial Osteomyelitis (CNO) is an inflammatory disorder that
primarily affects children. Although underestimated, its incidence is rare. For these reasons, no …